GZYK(SZ:002524) Zheng Quan Shi Bao Wang·2025-12-05 03:19Core Insights - The collaboration between Tongji University Affiliated Tongji Hospital and Guangzheng Ophthalmology has led to the development of innovative glaucoma drainage valves and anterior chamber puncture devices, winning multiple awards at national competitions [1][2] Group 1: Awards and Recognition - The glaucoma treatment patent won first prize and third prize at the 2025 China Medical Device Innovation and Entrepreneurship Competition, and second prize at the 2025 Yangtze River Delta Industrial Innovation Patent Operation Competition [1] - The awarded patents are now entering subsequent research trials and clinical application phases, supported by collaborations and financing from several well-known medical technology companies [2] Group 2: Collaborative Innovation - Guangzheng Ophthalmology has established three major innovation platforms in collaboration with top institutions, focusing on AI ophthalmic diagnostic systems and minimally invasive treatment device development [3] - The recent patent breakthrough in glaucoma treatment reflects the success of Guangzheng Ophthalmology's innovation research system, emphasizing its commitment to driving advancements in ophthalmic medical technology [3] Group 3: Future Directions - Guangzheng Ophthalmology plans to leverage the recent awards to deepen its focus on the "AI + healthcare" sector, enhancing partnerships with academic and research institutions [3] - The company aims to increase investment in cutting-edge fields such as AI diagnosis and gene therapy, integrating innovative results into its medical service network for broader patient benefit [3]